Assertio Therapeutics's market cap is currently $77.34M. The company's EPS TTM is $-0.722; its P/E ratio is ―; Assertio Therapeutics is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 152.07M	$ 156.23M	$ 111.01M	$ 106.28M	$ 229.50M
Gross Profit	$ 125.05M	$ 137.49M	$ 95.18M	$ 86.40M	$ 220.00M
Operating Income	$ -243.54M	$ 57.81M	$ 9.42M	$ -46.92M	$ 3.20M
EBITDA	$ -222.45M	$ 72.53M	$ 38.78M	$ -3.20M	$ -61.12M
Net Income	$ -331.94M	$ 109.63M	$ -1.28M	$ -28.14M	$ -217.20M
Balance Sheet
Cash & Short-Term Investments	$ 73.44M	$ 64.94M	$ 36.81M	$ 20.79M	$ 42.11M
Total Assets	$ 286.42M	$ 413.91M	$ 326.55M	$ 303.27M	$ 527.17M
Total Debt	$ 40.91M	$ 66.87M	$ 73.49M	$ 84.10M	$ 351.26M
Net Debt	$ -32.53M	$ 1.93M	$ 36.68M	$ 63.32M	$ 309.15M
Total Liabilities	$ 148.42M	$ 188.19M	$ 224.13M	$ 247.76M	$ 469.21M
Stockholders' Equity	$ 138.00M	$ 225.72M	$ 102.41M	$ 55.51M	$ 57.96M
Cash Flow
Free Cash Flow	$ 48.98M	$ 78.32M	$ 5.47M	$ -65.58M	$ 88.99M
Operating Cash Flow	$ 49.60M	$ 78.60M	$ 5.52M	$ -65.57M	$ 90.47M
Investing Cash Flow	$ 3.10M	$ -42.67M	$ -18.52M	$ 512.80M	$ -1.48M
Financing Cash Flow	$ -44.20M	$ -7.79M	$ 29.03M	$ -468.55M	$ -157.84M

Currency in USD

Assertio Therapeutics Earnings and Revenue History

Income Statement >

Assertio Therapeutics Debt to Assets

Balance Sheet >

Assertio Therapeutics Cash Flow

Cash Flow >

Assertio Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing